William W. Bullen

431 total citations
13 papers, 378 citations indexed

About

William W. Bullen is a scholar working on Molecular Biology, Oncology and Spectroscopy. According to data from OpenAlex, William W. Bullen has authored 13 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Spectroscopy. Recurrent topics in William W. Bullen's work include Analytical Chemistry and Chromatography (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and Enzyme function and inhibition (2 papers). William W. Bullen is often cited by papers focused on Analytical Chemistry and Chromatography (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and Enzyme function and inhibition (2 papers). William W. Bullen collaborates with scholars based in United States, Germany and Canada. William W. Bullen's co-authors include Roger N. Hayes, Ronald Miller, Edward R.B. McCabe, Stephen I. Goodman, Mary Anne Guggenheim, Edward H. Kerns, Richard E. Gammans, Manuel G. Roig, Gary M. Lum and Steven P. Ringel and has published in prestigious journals such as Annals of Neurology, Biochemical and Biophysical Research Communications and Life Sciences.

In The Last Decade

William W. Bullen

12 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William W. Bullen United States	9	181	97	61	51	49	13	378
Miyoshi Fukui Japan	13	202 1.1×	40 0.4×	73 1.2×	18 0.4×	25 0.5×	32	527
Stella Vincent United States	16	285 1.6×	49 0.5×	58 1.0×	34 0.7×	97 2.0×	35	712
Yasutaka Igari Japan	14	152 0.8×	25 0.3×	63 1.0×	26 0.5×	44 0.9×	19	603
Dwight D. Stiff United States	13	158 0.9×	50 0.5×	34 0.6×	8 0.2×	22 0.4×	18	444
David J. Spalding United Kingdom	13	154 0.9×	19 0.2×	28 0.5×	42 0.8×	15 0.3×	21	579
Hilman W. Culp United States	13	195 1.1×	40 0.4×	61 1.0×	6 0.1×	32 0.7×	19	641
William J. Leavens United Kingdom	12	233 1.3×	97 1.0×	381 6.2×	33 0.6×	21 0.4×	18	654
Kiyoshi Oizumi Japan	16	228 1.3×	32 0.3×	16 0.3×	15 0.3×	23 0.5×	28	588
Mark L. J. Reimer Canada	8	161 0.9×	15 0.2×	56 0.9×	40 0.8×	12 0.2×	17	412
Nicola Giacchè Italy	13	283 1.6×	15 0.2×	40 0.7×	36 0.7×	28 0.6×	22	719

Countries citing papers authored by William W. Bullen

Since Specialization

Citations

This map shows the geographic impact of William W. Bullen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William W. Bullen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William W. Bullen more than expected).

Fields of papers citing papers by William W. Bullen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William W. Bullen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William W. Bullen. The network helps show where William W. Bullen may publish in the future.

Co-authorship network of co-authors of William W. Bullen

This figure shows the co-authorship network connecting the top 25 collaborators of William W. Bullen. A scholar is included among the top collaborators of William W. Bullen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William W. Bullen. William W. Bullen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Bullen, William W., Ronald Miller, & Roger N. Hayes. (1999). Development and validation of a high-performance liquid chromatography tandem mass spectrometry assay for atorvastatin, ortho-hydroxy atorvastatin, and para-hydroxy atorvastatin in human, dog, and rat plasma. Journal of the American Society for Mass Spectrometry. 10(1). 55–66. 120 indexed citations

Bullen, William W., Chetan Lathia, Robert Abel, & Roger N. Hayes. (1998). Validated HPLC/MS/MS assay for CI-1011 in rat plasma and a comparison with an HPLC/UV assay. Journal of Pharmaceutical and Biomedical Analysis. 17(8). 1399–1413. 2 indexed citations

Bullen, William W., David T. Rossi, Keith L. Hoffman, Ajit Suri, & Chetan Lathia. (1997). An HPLC assay utilizing solid-phase extraction for CI-1010, an alkylating radiosensitizer, in rat plasma. Journal of Pharmaceutical and Biomedical Analysis. 16(1). 47–55.

Bullen, William W., Lloyd R. Whitfield, Gary A. Walter, & Joanne Brodfuehrer. (1995). High-performance liquid chromatographic assay for CI-980, a novel 1-deaza-7,8-dihydropteridine anticancer agent, in human plasma and urine. Journal of Chromatography B Biomedical Sciences and Applications. 668(1). 141–151. 4 indexed citations

Bullen, William W., et al.. (1992). A high-performance liquid chromatographic assay for CI-973, a new anticancer platinum diamine complex, in human plasma and urine ultrafiltrates. Cancer Chemotherapy and Pharmacology. 30(3). 193–198. 4 indexed citations

Kerns, Edward H., William W. Bullen, & Richard E. Gammans. (1986). Quantitative analysis of 1-(2-pyrimidinyl)piperazine in plasma by capillary gas chromatography—mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 377. 195–203. 12 indexed citations

Gammans, Richard E., Edward H. Kerns, & William W. Bullen. (1985). Capillary gas chromatographic—mass spectrometric determination of buspirone in plasma. Journal of Chromatography B Biomedical Sciences and Applications. 345(2). 285–297. 30 indexed citations

Gammans, Richard E., et al.. (1985). Gas chromatographic—mass spectrometric method for trazodone and a deuterated analogue in plasma. Journal of Chromatography B Biomedical Sciences and Applications. 339(2). 303–312. 14 indexed citations

Seltzer, William, William W. Bullen, & Edward R.B. McCabe. (1983). Human glycerol kinase: Comparison of properties from fibroblasts and liver. Life Sciences. 32(15). 1721–1726. 9 indexed citations

10.

McCabe, Edward R.B., et al.. (1982). Human glycerol kinase deficiency: Enzyme kinetics and fibroblast hybridization. Journal of Inherited Metabolic Disease. 5(4). 177–182. 20 indexed citations

11.

Guggenheim, Mary Anne, Edward R.B. McCabe, Manuel G. Roig, et al.. (1980). Glycerol kinase deficiency with neuromuscular, skeletal, and adrenal abnormalities. Annals of Neurology. 7(5). 441–449. 79 indexed citations

12.

Stumpf, David A., et al.. (1979). Loosely coupled mitochondrial oxidative phosphorylation induced by protoporphyrin. Biochemical Medicine. 21(2). 182–189. 19 indexed citations

13.

McCabe, Edward R.B., Paul V. Fennessey, Mary Anne Guggenheim, et al.. (1977). Human glycerol kinase deficiency with hyperglycerolemia and glyceroluria. Biochemical and Biophysical Research Communications. 78(4). 1327–1333. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact